↓ Skip to main content

Bromelain and N-acetylcysteine inhibit proliferation and survival of gastrointestinal cancer cells in vitro: significance of combination therapy

Overview of attention for article published in Journal of Experimental & Clinical Cancer Research, November 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (91st percentile)
  • High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

blogs
1 blog
twitter
20 X users
facebook
1 Facebook page

Citations

dimensions_citation
46 Dimensions

Readers on

mendeley
75 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Bromelain and N-acetylcysteine inhibit proliferation and survival of gastrointestinal cancer cells in vitro: significance of combination therapy
Published in
Journal of Experimental & Clinical Cancer Research, November 2014
DOI 10.1186/s13046-014-0092-7
Pubmed ID
Authors

Afshin Amini, Samar Masoumi-Moghaddam, Anahid Ehteda, David Lawson Morris

Abstract

Bromelain and N-acetylcysteine are two natural, sulfhydryl-containing compounds with good safety profiles which have been investigated for their benefits and application in health and disease for more than fifty years. As such, the potential values of these agents in cancer therapy have been variably reported in the literature. In the present study, the efficacy of bromelain and N-acetylcysteine in single agent and combination treatment of human gastrointestinal carcinoma cells was evaluated in vitro and the underlying mechanisms of effect were explored.

X Demographics

X Demographics

The data shown below were collected from the profiles of 20 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 75 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Canada 1 1%
Unknown 74 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 16 21%
Student > Ph. D. Student 11 15%
Student > Bachelor 8 11%
Researcher 7 9%
Student > Doctoral Student 4 5%
Other 6 8%
Unknown 23 31%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 16 21%
Medicine and Dentistry 7 9%
Agricultural and Biological Sciences 6 8%
Pharmacology, Toxicology and Pharmaceutical Science 5 7%
Engineering 3 4%
Other 12 16%
Unknown 26 35%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 19. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 February 2024.
All research outputs
#1,955,220
of 25,591,967 outputs
Outputs from Journal of Experimental & Clinical Cancer Research
#71
of 2,411 outputs
Outputs of similar age
#21,946
of 271,499 outputs
Outputs of similar age from Journal of Experimental & Clinical Cancer Research
#1
of 17 outputs
Altmetric has tracked 25,591,967 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,411 research outputs from this source. They receive a mean Attention Score of 4.8. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 271,499 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 17 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 94% of its contemporaries.